Viewing Study NCT07260669

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2026-04-08 @ 7:58 AM
Study NCT ID: NCT07260669
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2025-09-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Sponsor: Gesynta Pharma AB
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Endometriosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-menstrual pelvic pain View
None Dysmenorrhea View
None Pelvic pain View